The Wall Street Journal-20080122-Indian Companies Settle Drug Suit
来自我不喜欢考试-知识库
Return to: The_Wall_Street_Journal-20080122
Indian Companies Settle Drug Suit
Full Text (63 words)
India's Ranbaxy Laboratories Ltd. and Dr. Reddy's Laboratories Ltd. said they settled generic-drug litigation with GlaxoSmithKline PLC and Novartis AG, respectively.
Ranbaxy, India's largest pharmaceutical company by sales, said the settlement over sumatriptan succinate, the generic version of GlaxoSmithKline's Imitrex, will allow Ranbaxy to sell the drug in the U.S. for 180 days starting in December without competing against any other generic version.
